Advanced Medical Solutions Grp PLC Director/PDMR and PCA Shareholding (4901E)
July 18 2016 - 9:57AM
UK Regulatory
TIDMAMS
RNS Number : 4901E
Advanced Medical Solutions Grp PLC
18 July 2016
18 July 2016
Advanced Medical Solutions Group plc
("AMS", the "Company" or the "Group")
Director/PDMR and PCA Shareholding
Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS), a
leading developer and manufacturer of advanced products for the
global surgical and wound care markets, announces that it was
notified on 14 July 2016 that Simon Coates, a Senior Manager and
PDMR, had exercised 16,188 Ordinary Shares of 5p from the Deferred
Share Bonus Plan, sold 5,768 shares from the total shares exercised
(to satisfy income tax/National Insurance liabilities) and
transferred 10,420 shares to Angela Coates (Simon Coates's wife).
In addition Simon Coates transferred 10,000 shares held in his name
to a nominee account.
AMS was also notified that Pieter van Hoof, a Senior Manager and
PDMR, had exercised 25,000 Ordinary Shares of 5p from the Long-Term
Investment Plan and sold 11,809 shares from the total shares
exercised (to satisfy income tax/National Insurance
liabilities).
The two notifications below, made in accordance with the
requirements of the EU Market Abuse Regulation, provide further
detail.
Notification and public disclosure of transactions by persons
discharging managerial responsibilities and persons closely
associated with them
1. Details of the person discharging managerial
responsibilities/person closely associated
--- -----------------------------------------------------------------------
a) Name: Simon Coates
--- -----------------------------------------------------------------------
2. Reason for the notification
--- -----------------------------------------------------------------------
a) Position/status: Senior Manager/PDMR
--- -----------------------------------------------------------------------
b) Initial notification/Amendment: Initial
Notification
--- -----------------------------------------------------------------------
3. Details of the issuer, emission allowance
market participant, auction platform, auctioneer
or auction monitor
--- -----------------------------------------------------------------------
a) Name: Advanced Medical Solutions Group
plc
--- -----------------------------------------------------------------------
b) LEI: 213800HJP6OWOSZI1L74
--- -----------------------------------------------------------------------
4. Details of the transaction(s): section
to be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transactions
have been conducted
--- -----------------------------------------------------------------------
a) Description of the financial instrument,
type of instrument: Ordinary Shares of
5p
Identification code: GB0004536594
--- -----------------------------------------------------------------------
b) Nature of the transaction:
* Exercise of 16,188 Ordinary Shares of 5p from the
Deferred Share Bonus Plan;
* Sale of 5,768 shares from the total shares exercised
(to satisfy income tax/National Insurance
liabilities);
* Transfer of 10,420 shares to Angela Coates (Simon
Coates's wife); and
* Transfer of 10,000 shares to a nominee account.
--- -----------------------------------------------------------------------
c) Price(s) and volume(s):
Exercise of Deferred Share Bonus Plan: Price(s) Volume(s)
------------------- ----------
Nil consideration 16,188
------------------- ----------
Sale of shares: Price(s) Volume(s)
------------- ----------
GBP1.983547 5,768
------------- ----------
Transfer to Angela Coates: Price(s) Volume(s)
------------------- ----------
Nil consideration 10,420
------------------- ----------
Transfer to a nominee account: Price(s) Volume(s)
------------------- ----------
Nil consideration 10,000
------------------- ----------
--- -----------------------------------------------------------------------
d) Aggregated information: (Relates to those
shares sold only)
Aggregated volume: 5,768
Aggregated price: GBP1.983547
--- -----------------------------------------------------------------------
e) Date of the transaction: 14/07/2016
--- -----------------------------------------------------------------------
f) Place of the transaction: London Stock
Exchange, AIM Market (XLON)
--- -----------------------------------------------------------------------
1. Details of the person discharging managerial
responsibilities/person closely associated
--- ------------------------------------------------------------------
a) Name: Pieter van Hoof
--- ------------------------------------------------------------------
2. Reason for the notification
--- ------------------------------------------------------------------
a) Position/status: Senior Manager/PDMR
--- ------------------------------------------------------------------
b) Initial notification/Amendment: Initial
Notification
--- ------------------------------------------------------------------
3. Details of the issuer, emission allowance
market participant, auction platform, auctioneer
or auction monitor
--- ------------------------------------------------------------------
a) Name: Advanced Medical Solutions Group
plc
--- ------------------------------------------------------------------
b) LEI: 213800HJP6OWOSZI1L74
--- ------------------------------------------------------------------
4. Details of the transaction(s): section
to be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transactions
have been conducted
--- ------------------------------------------------------------------
a) Description of the financial instrument,
type of instrument: Ordinary Shares of
5p
Identification code: GB0004536594
--- ------------------------------------------------------------------
b) Nature of the transaction:
* Exercise of 25,000 Ordinary Shares of 5p from the
Long-Term Investment Plan; and
* Sale of 11,809 shares from the total shares exercised
(to satisfy income tax/National Insurance
liabilities).
--- ------------------------------------------------------------------
c) Price(s) and volume(s):
Exercise of options: Price(s) Volume(s)
---------------- ----------
GBP1 total
consideration 25,000
---------------- ----------
Sale of shares: Price(s) Volume(s)
------------- ----------
GBP1.983547 11,809
------------- ----------
--- ------------------------------------------------------------------
d) Aggregated information: (relates to sale
shares only)
Aggregated volume: 11,809
Aggregated price: GBP1.983547
--- ------------------------------------------------------------------
e) Date of the transaction: 14/07/2016
--- ------------------------------------------------------------------
f) Place of the transaction: London Stock
Exchange, AIM Market (XLON)
--- ------------------------------------------------------------------
- End -
For further information, please visit www.admedsol.com or
contact:
Advanced Medical Solutions Group Tel: +44 (0)
plc 1606 545508
Chris Meredith, Chief Executive
Officer
Mary Tavener, Group Finance Director
Consilium Strategic Communications Tel: +44 (0)
20 3709 5700
Mary-Jane Elliott / Jonathan AMS@consilium-comms.com
Birt / Matthew Neal / Hendrik
Thys
Investec Bank PLC (NOMAD & Broker) Tel: +44 (0)
20 7597 5970
Gary Clarence / Daniel Adams
/ Patrick Robb
About Advanced Medical Solutions Group plc - see
www.admedsol.com
AMS is a world-leading independent developer and manufacturer of
innovative and technologically advanced products for the global
surgical, wound care and wound closure markets, focused on quality
outcomes for patients and value for payors. AMS has a wide range of
products that include silver alginates, alginates, foams, tissue
adhesives, sutures and haemostats, which it markets under its
brands; ActivHeal(R), LiquiBand(R) and RESORBA(R) as well as
supplying under white label.
AMS's products, manufactured out of two sites in the UK, one in
the Netherlands, two in Germany and one in the Czech Republic, are
sold in more than 70 countries via a network of multinational or
regional partners and distributors, as well as via AMS's own direct
sales forces in the UK, Germany, the Czech Republic and Russia.
Established in 1991, the Company has 510 employees. For more
information please see www.admedsol.com.
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHLLFEVDRITLIR
(END) Dow Jones Newswires
July 18, 2016 09:57 ET (13:57 GMT)
Advanced Medical Solutions (LSE:AMS)
Historical Stock Chart
From Mar 2024 to Apr 2024
Advanced Medical Solutions (LSE:AMS)
Historical Stock Chart
From Apr 2023 to Apr 2024